A couple of stocks that are doing exceptionally well this year are Veru (NASDAQ: VERU) and Chevron (NYSE: CVX). Pharmaceutical company Veru has been among the hottest stocks to own this year, having more than doubled in value while the S&P 500 is firmly in negative territory, down 13%. The company and its investors are hoping that the Food and Drug Administration (FDA) grants it Emergency Use Authorization (EUA) as phase 3 trials have shown it is effective in reducing the risk of death among hospitalized patients.